Form 4 for CDNA CareDx, Inc.

Accepted 2026-02-04 00:00:00 ET · period of report 2026-02-02 · accession 0001781127-26-000003 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2026-02-04	2026-02-02	CDNA	Hanna John Walter JR	Pres, CEO, Dir	A - Grant	$0.00	+200.1K	759.9K	+36%	$0
	2026-02-04	2026-02-02	CDNA	Hanna John Walter JR	Pres, CEO, Dir	F - Tax	$20.42	-13.7K	783.8K	-2%	-$279.6K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2026-02-02	A	A	37,632	$0.00	797,537	D	—	—	(F2) The reported securities were subject to a performance restricted stock unit ("PRSU") award that was initially granted on February 1, 2025, and were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation and Human Capital Committee of the Issuer's Board of Directors on February 2, 2026.
2	Common	Common Stock	2026-02-02	A	A	162,500	$0.00	759,905	D	—	—	(F1) The reported securities are represented by restricted stock units ("RSUs"), of which one-third will vest on April 6, 2027 and the remaining two-thirds will vest in equal quarterly installments thereafter on the last day of each of the subsequent eight quarters, rounded down to the nearest whole share until the last such installment, such that one-hundred percent of the RSUs will be vested on the third anniversary of April 6, 2027, subject to the Reporting Person's continuous employment on each applicable vesting date.
3	Common	Common Stock	2026-02-02	F	D	13,694	$20.42	783,843	D	—	—	(F3) These shares were withheld by the Issuer in order to satisfy certain tax withholding obligations in connection with the issuance of shares upon the vesting of PRSUs.